HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.

Abstract
Intrauterine blood transfusion is the mainstay of treatment of fetal rhesus hemolytic anemia with optimal perinatal outcome. Postnatal immunoglobulin therapy has been successfully used in the management of alloimmunized neonates and has shown to decrease the need for exchange transfusion. We report the first case series of fetal immunoglobulin therapy in the antenatal management of severe Rh incompatibility.
AuthorsAlka Kriplani, Bhawna Malhotra Singh, Kavita Mandal
JournalGynecologic and obstetric investigation (Gynecol Obstet Invest) Vol. 63 Issue 3 Pg. 176-80 ( 2007) ISSN: 0378-7346 [Print] Switzerland
PMID17143009 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright (c) 2007 S. Karger AG, Basel.
Chemical References
  • Immunoglobulins, Intravenous
  • Isoantibodies
Topics
  • Adult
  • Anemia, Hemolytic (immunology, therapy)
  • Blood Transfusion, Intrauterine (methods)
  • Female
  • Fetal Diseases (immunology, therapy)
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Infant, Newborn
  • Isoantibodies (blood, immunology)
  • Pregnancy
  • Pregnancy Complications
  • Pregnancy Outcome
  • Rh Isoimmunization (immunology, therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: